Histocell, S.L.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Mar 2030
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 14, 2027The maintenance fee for Treatment method for mesenchymal stem cells and their application as a treatment of oxidative stress related diseases (US 9,080,153) comes due Jan 14, 2027. Unpaid by Jul 14, 2027, it lapses early.
- 1 fee due Oct 26, 2027The maintenance fee for Three-dimensional matrices of structured porous monetite for tissue engineering and bone regeneration, and method of the preparation thereof (US 9,320,828) comes due Oct 26, 2027. Unpaid by Apr 26, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 6 of 6
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,320,828 | Three-dimensional matrices of structured porous monetite for tissue engineering and bone regeneration, and method of the preparation thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 10,226,480 | Biomaterial from Wharton's Jelly Umbilical Cord In force · Medium confidence | In force | Medium confidence | |
| US 9,492,475 | Antioxidant composition In force · From the USPTO record | In force | From the USPTO record | |
| US 10,231,992 | Antioxidant composition In force · From the USPTO record | In force | From the USPTO record | |
| US 9,080,153 | Treatment method for mesenchymal stem cells and their application as a treatment of oxidative stress related diseases In force · From the USPTO record | In force | From the USPTO record | |
| US 11,241,516 | Biomaterial scaffold for regenerating the oral mucosa In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 6: 2 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending